Categories | SLE patients (n = 77) | Healthy controls (n = 43) |
---|---|---|
General conditions | ||
Female,% | 91Â % | 77Â % |
Age, years, average ± SD | 35 ± 13 | 32 ± 11 |
SLEDAI, median (range) | 4 (0–14) |  |
Clinical features, number of patients | ||
 Fever | 5 |  |
 Cutaneous manifestations | 12 |  |
 Oral ulcer | 3 |  |
 Alopecia | 5 |  |
 Arthritis | 11 |  |
 Raynaud’s phenomenon | 5 |  |
 Effusion | 3 |  |
 Renal involvement | 27 |  |
Laboratory parameters, number of patients | ||
 Leucopenia | 8 |  |
 Erythrocytopenia | 20 |  |
 Thrombocytopenia | 5 |  |
 Anemia | 29 |  |
 Pyuria | 13 |  |
 Hematuria | 6 |  |
 Proteinuria | 16 |  |
 Anti-dsDNA(+) | 27 |  |
 Increased ANA (>1:320) | 27 |  |
Anti-ENA (39 patients) | ||
 Anti-Sm | 15 |  |
 Anti-Ro52 | 24 |  |
 Anti-nRNP/Sm | 24 |  |
 Anti-Rrnp | 16 |  |
 Anti-nucleosome | 13 |  |
 Anti-SSA | 29 |  |
 Anti-SSB | 10 |  |
Decreased C3/C4 | 38/31 | Â |
Increased IgG | 24 | Â |
Elevated ESR/CRP | 38/10 | Â |